PPARG and cancer: Platinum-based drugs arecurrently being used in the clinic to treat lung and ovarian cancer, therefore,the use of PPARγ ligands to enhance the efficacy of platinumdrugs in the treatment of these cancers would be a great advancement intreating these two deadly diseases.